Caplin ME - Search Results

1

Diagnostic and therapeutic advances in neuroendocrine tumours.

Caplin ME, Ratnayake GM. Caplin ME, et al. Nat Rev Endocrinol. 2021 Feb;17(2):81-82. doi: 10.1038/s41574-020-00458-x. Nat Rev Endocrinol. 2021. PMID: 33335329 Review. No abstract available.

2

Middle ear neuroendocrine tumours: Insight into their pathogenesis, diagnosis and management.

Ratnayake GM, Luong TV, Toumpanakis C, Caplin M, Grossman AB. Ratnayake GM, et al. J Neuroendocrinol. 2021 Aug 13;33(9):e13031. doi: 10.1111/jne.13031. Online ahead of print. J Neuroendocrinol. 2021. PMID: 34462974

3

What Causes Desmoplastic Reaction in Small Intestinal Neuroendocrine Neoplasms?

Ratnayake GM, Laskaratos FM, Mandair D, Caplin ME, Rombouts K, Toumpanakis C. Ratnayake GM, et al. Among authors: caplin me. Curr Oncol Rep. 2022 Oct;24(10):1281-1286. doi: 10.1007/s11912-022-01211-5. Epub 2022 May 13. Curr Oncol Rep. 2022. PMID: 35554845 Free PMC article. Review.

4

Epidermal growth factor receptor expression and activation in neuroendocrine tumours.

Shah T, Hochhauser D, Frow R, Quaglia A, Dhillon AP, Caplin ME. Shah T, et al. Among authors: caplin me. J Neuroendocrinol. 2006 May;18(5):355-60. doi: 10.1111/j.1365-2826.2006.01425.x. J Neuroendocrinol. 2006. PMID: 16629834

5

Cytotoxic treatment including embolization/chemoembolization for neuroendocrine tumours.

Toumpanakis C, Meyer T, Caplin ME. Toumpanakis C, et al. Among authors: caplin me. Best Pract Res Clin Endocrinol Metab. 2007 Mar;21(1):131-44. doi: 10.1016/j.beem.2007.01.005. Best Pract Res Clin Endocrinol Metab. 2007. PMID: 17382269 Review.

6

Review article: future therapies for management of metastatic gastroenteropancreatic neuroendocrine tumours.

Srirajaskanthan R, Toumpanakis C, Meyer T, Caplin ME. Srirajaskanthan R, et al. Among authors: caplin me. Aliment Pharmacol Ther. 2009 Jun 1;29(11):1143-54. doi: 10.1111/j.1365-2036.2009.03988.x. Epub 2009 Mar 2. Aliment Pharmacol Ther. 2009. PMID: 19298583 Free article. Review.

7

Expression of somatostatin and dopamine 2 receptors in neuroendocrine tumours and the potential role for new biotherapies.

Srirajaskanthan R, Watkins J, Marelli L, Khan K, Caplin ME. Srirajaskanthan R, et al. Among authors: caplin me. Neuroendocrinology. 2009;89(3):308-14. doi: 10.1159/000179899. Epub 2009 Mar 23. Neuroendocrinology. 2009. PMID: 19307732

8

A stepwise approach to the management of metastatic midgut carcinoid tumor.

Bhattacharyya S, Gujral DM, Toumpanakis C, Dreyfus G, Davidson BR, Davar J, Caplin ME. Bhattacharyya S, et al. Among authors: caplin me. Nat Rev Clin Oncol. 2009 Jul;6(7):429-33. doi: 10.1038/nrclinonc.2009.70. Nat Rev Clin Oncol. 2009. PMID: 19561636

9

Expression of the HER-1-4 family of receptor tyrosine kinases in neuroendocrine tumours.

Srirajaskanthan R, Shah T, Watkins J, Marelli L, Khan K, Caplin ME. Srirajaskanthan R, et al. Among authors: caplin me. Oncol Rep. 2010 Apr;23(4):909-15. doi: 10.3892/or_00000714. Oncol Rep. 2010. PMID: 20204273

10

Chemotherapy with 5-fluorouracil, cisplatin and streptozocin for neuroendocrine tumours.

Turner NC, Strauss SJ, Sarker D, Gillmore R, Kirkwood A, Hackshaw A, Papadopoulou A, Bell J, Kayani I, Toumpanakis C, Grillo F, Mayer A, Hochhauser D, Begent RH, Caplin ME, Meyer T. Turner NC, et al. Among authors: caplin me. Br J Cancer. 2010 Mar 30;102(7):1106-12. doi: 10.1038/sj.bjc.6605618. Epub 2010 Mar 16. Br J Cancer. 2010. PMID: 20234360 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

239 results

Search Page